Blood Monocyte Cd163 Expression As a Biomarker in Hiv-1 Infection and Neuroaids

The invention provides a method for detecting CD163+/CD16+ cell population in peripheral blood mononuclear cells in a biological sample from a subject infected with HIV-1 which comprises contacting the biological sample with an anti-CD163 antibody, so that levels of CD163+/CD16+ peripheral blood mononuclear cells in the biological sample can be quantified. The method of the present invention is particularly useful for monitoring the course of HIV-1 infection and/or HIV Encephalopathy

Patents:
US 20,100,291,595

Inventor(s): RAPPAPORT JAY [US]; FISCHER-SMITH TRACY [US]

Type of Offer: Licensing



« More Medical Patents

---